Efficacy of Photodynamic Therapy in the Non-Surgical Treatment of Peri-Implantitis
PeriimpMAA
2 other identifiers
interventional
40
1 country
1
Brief Summary
Peri-implantitis is a growing public health problem that can lead to several complications and sequelae, with a serious impact on the health and quality of life of patients and a high cost for healthcare systems. Bacterial plaque that accumulates around dental implants leads to peri-implant tissue inflammation that ultimately can result in the loss of the implant, significant bone destruction and infection that can reach other regions. Successful implant decontamination is necessary to preserve the implant and several strategies have been suggested for this purpose, however, there is still no fully effective treatment modality and failures and recurrence are relatively frequent. To better understand this problem and develop more effective treatment strategies, investigators will first conduct an epidemiological study to understand the factors associated with the development of this pathology. Although there is data at an international level, the incidence of this problem in Portugal has not yet been properly studied. Later investigators will conduct a randomized clinical trial to evaluate the 6-week clinical outcomes of patients treated with a photodynamic therapy as an adjuvant versus the use of conventional titanium implant curettes for implant surface decontamination in the non-surgical treatment. Sixty patients/implants with peri-implantitis and within the established criteria, will undergo non-surgical treatment with one of the two protocols being studied. Various clinical and radiographic parameters will be evaluated, such as probing depth, insertion loss, recession, bleeding on probing, suppuration, peri-implant crevicular fluid volume, alveolar bone loss and peri-implantitis microbiome will be evaluated before surgery and 6 weeks after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2025
CompletedFirst Submitted
Initial submission to the registry
September 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2027
September 25, 2025
September 1, 2025
1.2 years
September 16, 2025
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Probing Depth
Measuring in milimeters the distance from the gingival margin to the base of a sulcus or peri-implant pocket, using a periodontal probe.
From enrollment to the end of treatment at 3 months
Secondary Outcomes (5)
Clinical attachment level
From enrollment to the end of treatment at 3 months.
Bleeding on Probing
From enrollment to the end of treatment at 3 months.
Suppuration
From enrollment to the end of treatment at 3 months.
Radiographic bone level
From enrollment to the end of treatment at 3 months.
Microbiology outcome
From enrollment to the end of treatment at 3 months.
Study Arms (2)
Control Group
ACTIVE COMPARATORMechanical debridment with titanium curettes and ultrasounds
Study Group
EXPERIMENTALMechanical debridment with titanium curettes and ultrasounds + aPDT (antimicrobial photodynamic therapy)
Interventions
Removal of deposits above and below the gum line using hand or ultrasonic tools to reduce the inflammatory parameters
Non-invasive treatment that uses a combination of a light-sensitive compound (photosensitizer), specific light and oxygen to generate reactive oxygen species (ROS) that kill bacteria
Eligibility Criteria
You may qualify if:
- patients over 18 years of age;
- patients with one or more implants diagnosed with peri-implantitis rehabilitated for at least one year;
- PI and GI \< 25%.
You may not qualify if:
- smoking patients;
- patients with uncontrolled periodontitis;
- systemic diseases that influence the study (diabetes);
- inadequate prosthetic rehabilitation that cannot be modified or that prevents access for physical decontamination;
- implants rehabilitated with cemented crowns;
- pregnant and lactating women;
- previous surgical intervention at the same site;
- therapy with non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics or immunosuppressants in the last 3 months;
- patients previously undergoing chemotherapy or radiotherapy;
- PI and IG \> 25%;
- uncooperative patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Egas Moniz School of Health and Science
Almada, Monte Da Caparica, 2829-511, Portugal
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo Alves, PhD
Egas Moniz School of Health and Science
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2025
First Posted
September 25, 2025
Study Start
May 14, 2025
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
July 30, 2027
Last Updated
September 25, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share